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Abstract 23 
Conventional in vivo directed evolution methods have primarily linked the biomolecule’s 24 
activity to bacterial cell growth. Recent developments instead rely on the conditional growth 25 
of bacteriophages (phages), viruses that infect and replicate within bacteria. Here we review 26 
recent phage-based selection systems for in vivo directed evolution. These approaches have 27 
been applied to evolve a wide range of proteins including transcription factors, polymerases, 28 
proteases, DNA-binding proteins, and protein-protein interactions. Advances in this field 29 
expand the possible applications of protein and RNA engineering. This will ultimately result in 30 
new biomolecules with tailor-made properties, as well as giving us a better understanding of 31 
basic evolutionary processes. 32 
 33 
Graphical abstract (submitted in separate TIFF file) 34 
 35 
 36 
Highlights (submitted in separate word file) 37 
 Directed evolution systems based on conditional phage replication (CPR) expand the 38 
potential of protein engineering. 39 
 CPR platforms function in both batch and continuous culture. 40 
 CPR systems bypass key limitations of conventional phage display. 41 
 Directed evolution of a wide range of proteins can be achieved by CPR. 42 
 43 
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Introduction 45 
Protein engineering enables the development of valuable biomolecules for pharmaceutical 46 
and biotechnological purposes. There are generally two strategies to guide protein 47 
engineering: rational design or directed evolution (Figure 1). Rational design usually uses 48 
computational tools and structural considerations to identify beneficial mutations in the 49 
protein of interest [1]. Recent advances in this strategy even allow the design of proteins 50 
completely de novo [2-6]. In comparison, directed evolution mimics natural evolution and 51 
starts with a population of genotype(s) and then proceeds with the iterative generation of 52 
genotype diversity and a selection based on linked phenotype activity. It is applied when too 53 
little structural or biochemical information is available to guide engineering. In many cases, 54 
these two strategies can be combined in a semi-rational approach to improve the activity of 55 
biomolecules [7,8]. This illustrates how the method must be chosen to fit the particular 56 
problem. 57 
 58 
A variety of directed evolution techniques have been developed that employ customized 59 
gene circuits [9-12]. One commonly used approach is to link the target protein’s activity to 60 
cell growth, which is particularly suitable when the evolving gene directly improves cellular 61 
fitness [13-15]. Alternatively, the use of phage particles offers a convenient way to uncouple 62 
the target protein’s activity from the fitness function of a cell. Instead, an artificial genetic 63 
circuit couples the evolving protein's function to increasingly efficient production of phage 64 
packaging the gene of interest [16]. 65 
 66 
Directed evolution requires genotypic diversity in the gene of interest and this can either be 67 
achieved in vivo or in vitro. In vivo mutagenesis relies on intracellular modification of the 68 
target gene [17-19] whereas in vitro mutagenesis can be achieved extracellularly by chemical 69 
modification [20], ultraviolet irradiation [21], or polymerase chain reaction (PCR) [22]. PCR-70 
based methods generally employ an error-prone polymerase or oligonucleotides that contain 71 
randomized bases at the desired positions. Chemical mutagenesis and irradiation are less 72 
commonly-used methods because of the lack of uniform mutational spectra [20,23]. By 73 
making randomized libraries or using a progressive series of mutations, it is possible to 74 
explore the ‘design space’ of a target gene, ultimately enabling the engineering of new 75 
proteins. 76 
 77 
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In this review, we first discuss the requirements for using phages to evolve biomolecules. We 78 
then focus on new directed evolution methods based on conditional phage replication that 79 
have been developed thanks to advances in molecular and synthetic biology. 80 
 81 
Re-engineering phage-host genetic interactions to select functional 82 
biomolecules 83 
When evolving a target gene from either a gene library or mutation system, the phenotype 84 
selection can either be performed outside a living cell (in vitro) or inside (in vivo). In vivo 85 
evolution systems allow selecting for more complex functions than in vitro methods (e.g. 86 
phage display) which are only suitable for binary protein-molecule interactions [24] (Figure 87 
2a). By contrast, intracellular evolution potentially allows selection for multi-step processes, 88 
as long as they can be linked to genotype survival [25]. For example, intracellular processes 89 
can facilitate the simultaneous mutation and selection of the gene of interest. Furthermore, it 90 
enables the use of counterselections against an undesired biomolecule function [26]. Another 91 
advantage of intracellular evolution is the subsequent compatibility of evolved genes or 92 
complex gene networks with the entire host cell machinery, as these have to function in a 93 
host cell context. To exploit these advantages, alternative phage-assisted directed evolution 94 
platforms have been developed. 95 
 96 
To allow enrichment of functional genes, phage selection systems require a link between the 97 
desired phenotype and conditional phage replication. This can be achieved by removing an 98 
essential gene required for phage replication from the phage genome and linking its 99 
expression to the function of the evolving biomolecule. Alternatively, this gene (or genes) 100 
could be a host co-factor required by the phage replication but dispensable to the cell (to 101 
allow cell survival in the uninfected cells that are required as a host reservoir). However, the 102 
only approaches developed so far rely on moving essential genes from the phage to the host 103 
cell or its associated plasmids [16,27] (Figure 2b,c). These systems may be classified 104 
according to the degree of phage engineering involved, where only a single gene may be 105 
moved or practically all of them. 106 
 107 
The evolving biomolecule has to be encoded in the phage and a genetic system has to be 108 
designed to allow a functional molecule to activate the expression of the essential gene 109 
(positive selection). When the evolving biomolecule is able to induce the expression of the 110 
missing gene, infectious virions will package the DNA encoding the biomolecule, promoting 111 
its survival. The conditional expression of the essential gene can be done at the 112 
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transcriptional or post-transcriptional levels, depending on the biomolecule to be evolved 113 
(e.g. a transcription factor or a riboregulator). 114 
 115 
Alternatively, selection may consist in designing a conditional interference with phage 116 
replication if a biomolecule is functional (negative selection). This is used to penalize any 117 
unwanted activity such as the original parental function of the biomolecule. The selection can 118 
also be complex or variable, where the stringency of positive and negative selection can be 119 
modulated exogenously [26]. 120 
 121 
Many alternative phage-host systems can in principle be chosen for the evolution of 122 
biomolecules depending on the application. For instance, if one wanted to evolve a 123 
photosynthetic protein, one might choose a cyanobacterium and one of its known phages. 124 
The disadvantage of such approaches is that the phage biology is not well characterized. 125 
Consequently, in this article we will focus on E. coli due to the lack of reported works with 126 
other organisms. The E. coli phages M13 [28], T4 [29,30], T7 [31] or λ [32] have been used 127 
to optimize protein function and stability with phage display, although M13 has been the only 128 
phage vector used to evolve biomolecules in vivo thus far. 129 
 130 
Evolving biomolecules through positive selection 131 
Recently, a new method to evolve biomolecules using M13 was developed, using a redesign 132 
of the host to implement a positive selection: Phage-Assisted Continuous Evolution (PACE) 133 
describes a general approach for the directed evolution of proteins in vivo [16]. Using PACE, 134 
new T7 RNA polymerase (RNAP) variants against a T3 promoter have been evolved, which 135 
are not bound by the wild-type T7 RNAP. For this, the minor coat protein pIII is replaced by 136 
the evolving gene of interest on the packaged M13 genome and the activity of the evolving 137 
protein is linked to conditional expression of pIII on a second plasmid, named an accessory 138 
plasmid (Figure 2b). Only phage particles assembled with pIII are infectious and propagate 139 
fast enough to stay in continuous culture. Mutations only accumulate within the packaged 140 
phage genome containing the target gene, and not in the E. coli strain, as bacteria are 141 
discarded (new uninfected bacteria are continuously provided). Enhanced genetic variation is 142 
obtained by a third mutagenesis plasmid (MP) that increases the mutation rate of E. coli cells 143 
[17]. All mutator genes on this MP are under an arabinose-inducible PBAD promoter allowing 144 
conditional mutagenesis only at the phage replication stage. In this way, a protein with 145 
desired characteristics can be evolved after dozens of reinfections within the continuous flow 146 
chamber. 147 
 148 
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Evolving biomolecules through negative selection 149 
In many cases, the requirements for evolved proteins not only include target activity but also 150 
the avoidance of potential off-target effects. This can be achieved by engineering a negative 151 
selection to remove variants with unwanted properties, which can be implemented by down-152 
regulating a gene required for phage replication [27,33]. Alternatively, one may exploit any of 153 
the known mechanisms by which a bacterium can counteract a phage infection [34]. PACE 154 
has been adapted for negative selection pressures by choosing an abortive infection 155 
mechanism, where the undesired activity (activation of the original promoter) was linked to 156 
the inhibition of phage propagation using a non-functional pIII variant [26]. 157 
 158 
Modulating selection stringency for new functions 159 
An important challenge is the ability to maintain phage replication when there is a lack of 160 
initial function for the biomolecule to be evolved. In the original PACE approach, an 161 
intermediate selection system was used where the T7 RNAP was initially evolved to 162 
transcribe a hybrid T3-T7 promoter, which had some activity, to later switch the selection to 163 
the full-target T3 promoter [16]. This is actually very difficult to achieve because it requires 164 
engineering a hybrid promoter that is still active with the original polymerase. Therefore this 165 
cannot be easily generalised to other cases. Fortunately, an alternative method was 166 
proposed that does not require re-engineering the target promoter [26] and instead relies on 167 
adding a second complementary copy of the gene used for selection (here gIII). This is 168 
similar to the hypothesis for the natural evolution of new functions de novo by gene 169 
duplication, where one gene duplicate maintains the original function, while the second copy 170 
is allowed to drift [35]. In the directed evolution case, the first gIII copy is under the control of 171 
a T3 promoter. The second copy is under the control of a T7 promoter, but the expression of 172 
this gIII is regulated (“stringency modulation”) to ensure this additional copy will cease to 173 
complement the original as the evolution progresses and the T7 RNAP acquires activity for 174 
the T3 promoter. Thus, the selection pressure is gradually increased over time to select the 175 
new function. 176 
 177 
Tackling complex evolution pressures 178 
Since the initial development of PACE, the platform has been adapted for the directed 179 
evolution of many different classes of proteins. For example, protease-PACE links the 180 
proteolysis of a target peptide to phage replication using a protease-activated RNA 181 
polymerase [36]. The system was used in the presence of two hepatitis C virus (HCV) 182 
protease inhibitor drug candidates (danoprevir and asunaprevir) to evolve HCV protease 183 
variants that possess up to 30-fold drug resistance. Strikingly, the predominant mutations 184 
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obtained in the HCV protease were consistent with the mutations observed in human 185 
patients treated with danoprevir or asunaprevir. Alternatively, DNA-binding PACE is a 186 
general method for the directed evolution of DNA-binding activity and specificity [25]. The 187 
platform was used to engineer transcription activator-like effector nucleases (TALENs) with 188 
improved DNA cleavage specificity [25]. On the other hand, protein-binding PACE enables 189 
the directed evolution of protein-protein interactions [37]. The authors evolved variants of the 190 
Bt toxin CrylAc against a cell receptor from the insect pest Trichoplusia ni with novel binding 191 
affinity that can ultimately overcome insect toxin resistance. PACE was also employed to 192 
continuously evolve T7 split RNA polymerases for downstream biosensor applications [38]. 193 
PACE has even been combined with high-throughput sequencing methods to improve 194 
downstream analysis which allows the characterization of whole protein populations as they 195 
adapt to selection pressures over time [39]. 196 
 197 
Evolution using phagemids 198 
Phagemids can provide an alternative to classic full-phage selection systems. They have 199 
specific advantages, such as large library sizes and avoiding the mutation of phage genes. 200 
Consequently, we developed a phagemid selection system [27,33] where only the phagemid 201 
(PM) containing a library member and one essential phage gene (gIII) is packaged, while all 202 
the other phage components (except gVI) are provided on a modified helper phage (HP). To 203 
complete the system, an accessory plasmid (AP) contains a conditional gene VI circuit 204 
(Figure 2c). After infection, a protein with desired activity upregulates gene VI expression 205 
and therefore increases phage production. In this way, a protein with desired activity can be 206 
selected after several rounds of reinfection. Notably, our recently described system [27,33] 207 
uses conditional production of the minor coat protein pVI instead of pIII used in PACE. This is 208 
particularly useful for the directed evolution of transcription factors against basally-active 209 
promoters as expressed gIII in the starter culture would otherwise cause infection resistance 210 
resulting in a significantly decreased selection efficiency [40,41]. 211 
 212 
Phagemid selection has been applied for the directed evolution of a set of orthogonal 213 
transcription factors based on λ cI against synthetic promoters [27]. Negative selection 214 
against wild-type (WT) activity via repression has been achieved by putting the WT DNA 215 
sequence between the -35 and -10 regions of each synthetic promoter. The resulting toolkit 216 
contains 12 transcription factors, operating as activators, repressors, dual activator-217 
repressors or dual repressor-repressors for the use in gene network engineering. Moreover, 218 
this evolution strategy functions in batch mode and therefore requires no special equipment 219 
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for reactor assembly, although it does rely on daily researcher interventions during selection 220 
[33]. 221 
 222 
Conclusion and perspectives 223 
Recently developed directed evolution methods based on conditional phage replication 224 
further emphasize the strengths of phage-assisted protein engineering. These systems are 225 
particularly useful as they bypass key limitations of the widely-used phage display technology 226 
such as the simultaneous mutation and selection of complex biological functions. When 227 
choosing the most suitable method, various aspects including desired protein activity, 228 
available structural information, selection pressure and required selection efficiency need to 229 
be considered. Intracellular phage-assisted systems can, in principle, be used for all types of 230 
proteins, as long as their activity can be linked to conditional phage production (Figure 3). 231 
Notably, this is easier to achieve for cytosolic proteins than it is for complex proteins (e.g. 232 
membrane proteins). Furthermore, general limitations of bacterial expression over 233 
mammalian expression such as protein solubility, posttranslational modifications and 234 
disulfide bond formation have to be taken into account when using any phage-assisted 235 
technology. 236 
 237 
Phages may also be used to evolve non-coding RNAs provided that their function can be 238 
linked to gene expression. This is particularly useful to complement computational designs of 239 
riboregulators [42], where a cognate regulatory sequence has to be added in the 5’UTR of 240 
the gene used for selection (for instance gene VI in [27,33]). Protein or RNA-based sensors 241 
(activating gene expression under the presence of a target chemical inducer) may also be 242 
encoded in the phage, provided one designs cycles of selections composed of two steps. 243 
The first step consists of a positive selection where the sensor may activate the infectious 244 
virion packaging in the presence of the chemical inducer. The second step occurs in the 245 
absence of the chemical inducer, where only sensors that do not activate the negative 246 
selection gene would be able to produce infectious virions. Similarly, negative selections may 247 
also be used to evolve the targeted function in the case of a negative regulator of gene 248 
expression (e.g., repressor). A negative selection would here act as an inverter such that 249 
constitutive phage replication could be used for evolving a repressor. 250 
 251 
Advances in the fields of DNA sequencing, gene synthesis and genome engineering will 252 
likely reduce costs and improve the efficiency of current phage-assisted systems as well as 253 
drive the development of new technologies based on bacteriophages other than M13 [43]. 254 
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These advances will also impact new mutagenesis strategies, in particular ones that enable 255 
targeted mutagenesis with improved mutation rates in vivo. The mutation of only the target 256 
gene(s) while not affecting any other genetic information is desirable in order to reduce the 257 
probability of selecting false positive variants in any directed evolution approach. As a 258 
consequence, phage-assisted evolution technologies will continue to play a key role in 259 
protein engineering efforts for basic as well as applied research. 260 
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Figures 474 
 475 
Figure 1. Protein engineering by rational design or directed evolution. a) Rational design uses 476 
computational tools as well as structural or other biochemical knowledge to identify beneficial 477 
mutations in the protein of interest. These mutations are inserted into the gene of interest (targeted 478 
mutagenesis) which is then expressed in host cells. Functional analysis for each protein variant is 479 
performed to confirm improved activity. b) Directed evolution is applied when too little structural or 480 
biochemical information is available to guide engineering. Mutations in the gene of interest are 481 
inserted randomly or by targeting specific positions in the gene sequence leading to a library of gene 482 
variants. Functional library members are then selected via a suitable selection system (e.g. phage-483 
assisted evolution) against a target function. The activity of the selected protein is finally confirmed by 484 
functional analysis. Rational design and directed evolution are often combined to obtain the best 485 
results (semi-rational approach). 486 
  487 
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 488 
Figure 2. Phage-assisted directed evolution methods. a) Affinity selection of library members by 489 
phage display. Protein variants are fused to a phage coat protein and are displayed on phage particles 490 
providing a physical connection between genotype and phenotype. b) Phage-assisted continuous 491 
evolution (PACE) is based on conditional M13 phage replication. The activity of the evolving protein on 492 
the selection phage (SP; contains the gene of interest and all phage genes except gene III) is linked to 493 
gIII expression on the accessory plasmid (AP; contains a conditional gene III expression circuit). Only 494 
phage particles assembled with pIII are infectious and propagate fast enough to stay in continuous 495 
culture. The system uses a mutagenesis plasmid (MP) that increases the mutation rate of E. coli cells 496 
to generate target gene diversity. Mutations only accumulate within the packaged phage genome 497 
containing the target gene and not in the E. coli strain due to the continuous nature of the system. In 498 
this way, a protein with desired characteristics can be evolved after dozens of rounds of reinfection. 499 
c) Phagemid-based evolution from combinatorial libraries in batch mode. The library members are 500 
located on a packaged phagemid (PM) which also contains one essential phage gene (gIII). All the 501 
other phage genes are located on a modified helper phage (HP; contains all phage genes except 502 
genes III and VI) and an accessory plasmid (AP; contains a conditional gene VI expression circuit). 503 
After infection, a protein with desired activity upregulates gene VI expression and therefore increases 504 
phage production. In this way, a protein with desired activity can be selected after several rounds of 505 
reinfection.  506 
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 508 
Figure 3. Directed evolution of different classes of proteins based on conditional M13 phage 509 
replication. a) An evolving T7 RNA polymerase upregulates gene III expression in an activity-510 
dependent manner [16]. b) An evolving N-terminal T7 RNA polymerase fused to a leucine zipper ZA 511 
assembles with a C-terminal T7 RNA polymerase variant fused to leucine zipper ZB leading to gene III 512 
expression in an activity-dependent manner [38]. c) An evolving transcription activator (e.g. λ cI) 513 
upregulates gene VI expression downstream of a specific promoter (e.g. λ PRM) [27]. d) DNA-binding 514 
PACE enables the evolution of transcription activator-like effector nucleases (TALENs) [25]. The 515 
evolving DNA-binding protein is linked to the ω subunit of bacterial RNA polymerase III and binding to 516 
a target DNA sequence upstream of a minimal lac promoter enables gene III expression in an activity-517 
dependent manner. e) Protease-PACE enables the evolution of proteases against desired cleavage 518 
sites [36]. The T7 polymerase is inhibited when bound to T7 lysozyme as it inhibits transcription 519 
initiation and the transition from initiation to elongation [44]. Proteolysis of the target cleavage site by 520 
an evolving protease activates the T7 RNA polymerase leading to gene III expression in an activity-521 
dependent manner. f) Protein-binding PACE allows the evolution of protein-protein interactions [37]. 522 
The target protein is bound to the DNA upstream the promoter PlacZ-opt via a fused DNA-binding 523 
domain (orange) and the RNA polymerase omega subunit (RpoZ; yellow) is fused to the evolving 524 
protein. The binding of the evolving protein to the target protein enables the transcription of gene III 525 
from the PlacZ-opt promoter. The evolving protein is highlighted in blue and the target sequence is 526 
depicted in red for each individual example. 527 
